Quarterly Consolidated Statement Of Cash Flows

Chiome Bioscience Inc. - Filing #7571351

Concept 2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
As at
2020-12-31
Quarterly consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-1,237,861,000 JPY
-1,466,400,000 JPY
Depreciation
1,476,000 JPY
2,956,000 JPY
Decrease (increase) in trade receivables
-89,761,000 JPY
31,321,000 JPY
Decrease (increase) in inventories
-12,488,000 JPY
30,212,000 JPY
Increase (decrease) in trade payables
2,056,000 JPY
-10,296,000 JPY
Other, net
-23,730,000 JPY
29,789,000 JPY
Subtotal
-1,208,689,000 JPY
-1,139,938,000 JPY
Interest paid
-1,323,000 JPY
-1,316,000 JPY
Income taxes paid
-3,240,000 JPY
-13,494,000 JPY
Net cash provided by (used in) operating activities
-1,191,009,000 JPY
-1,131,291,000 JPY
Cash flows from investing activities
Net cash provided by (used in) investing activities
JPY
-35,384,000 JPY
Cash flows from financing activities
Proceeds from issuance of shares
1,126,292,000 JPY
253,778,000 JPY
Other, net
0 JPY
JPY
Net cash provided by (used in) financing activities
1,127,291,000 JPY
271,345,000 JPY
Net increase (decrease) in cash and cash equivalents
-63,717,000 JPY
-895,330,000 JPY
Cash and cash equivalents
1,727,270,000 JPY
1,790,988,000 JPY
2,686,318,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.